The mean tumor volume of the 5-FU-based CRT group combined with the XPF–ERCC1 blocker was smaller than that of the 5-FU-based CRT group (561 mm3,446 mm3) in the HCT116 tumor (Figure 5B). This evidence concerns the gene ERCC4 and neoplasm.